Pakistan Declares War on Counterfeit Medicines: Mustafa Kamal Leads Nationwide Crackdown
Federal Health Minister Syed Mustafa Kamal has launched a sweeping national campaign to eliminate counterfeit and substandard medicines from Pakistan’s pharmaceutical supply chain. Reviving the National Task Force 2025, the initiative signals a new era of aggressive enforcement and public health protection.
Coordinated Action Begins May 19
Starting May 19, federal and provincial agencies—including the Drug Regulatory Authority of Pakistan (DRAP), Customs, FIA, and local healthcare regulators—will conduct:
- Surprise raids on pharmaceutical factories and retail outlets
- Market surveillance of distribution networks
- Inspections targeting drug quality and compliance
“Threats to human life and public trust are unacceptable,” Kamal declared, framing the campaign as a national emergency.
Empowering Citizens with Technology
To boost public engagement, DRAP will launch a mobile app that enables:
- Barcode scanning for instant medicine verification
- Reporting of suspicious products
- Real-time updates on drug shortages and adverse reactions
This digital tool is part of a broader push to modernize pharmaceutical oversight and empower consumers.
Mobilizing Resources for Maximum Impact
Minister Kamal has directed all relevant departments to deploy full operational capacity to root out fake and substandard drugs. He emphasized that every regulatory decision directly affects lives, reinforcing the government’s commitment to healthcare integrity and public welfare.
Rebuilding Trust in Healthcare
This crackdown is more than a regulatory sweep—it’s a strategic move to restore public confidence in Pakistan’s healthcare system. By ensuring medicine safety and transparency, the initiative aims to:
- Protect patients from harmful or ineffective treatments
- Strengthen pharmaceutical governance
- Promote ethical practices across the supply chain
+ There are no comments
Add yours